Brief: United Therapeutics Enters Credit Agreement With Wells Fargo - SEC Filing
28/04/2025 11:45
April 28 (Reuters) - United Therapeutics Corp UTHR.O: UNITED THERAPEUTICS CORP - ENTERS CREDIT AGREEMENT WITH WELLS FARGO - SEC FILING UNITED THERAPEUTICS CORP - CREDIT FACILITY UP TO $2.5 BILLION - SEC FILING UNITED THERAPEUTICS CORP - CREDIT FACILITY MAY INCREASE BY UP TO $750 MILLION - SEC FILING UNITED THERAPEUTICS CORP - TERMINATED 2022 CREDIT AGREEMENT WITH WELLS FARGO - SEC FILING Source text: [ID:n0001104659-25-039710] Further company coverage: UTHR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on United Therapeutics
See all newsBrief: United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization
Brief: United Therapeutics Announces FDA Clearance To Proceed With Summit Clinical Trial For Treprostinil Smi In Ph-Copd
Liquidia surges as United Therapeutics settlement removes key litigation risk (updated)
Brief: United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing
Liquidia surges after $381 million settlement with United Therapeutics for lung disease drug